Hemodynamic ABI Monitor
Non-invasive Continuous Hemodynamic Monitoring in Acute Brain Injury
1 other identifier
observational
50
1 country
1
Brief Summary
The goal of this observational study is to explore the relationship of heart function with the course and outcomes after traumatic brain injuries and nontraumatic intracerebral hemorrhage. The goal is to explore association between routinely collected hemodynamic and brain monitoring data. Participants already taking intervention A as part of their regular medical care and the investigators will follow up with participants 6 months after discharging the hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2024
CompletedStudy Start
First participant enrolled
December 6, 2024
CompletedFirst Posted
Study publicly available on registry
December 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 6, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 6, 2026
March 4, 2026
March 1, 2026
2 years
December 5, 2024
March 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
functional outcomes
Primary endpoints are functional outcomes and quality of life at 180 days after hospital discharge. The follow-up functional status and quality of life measures will be done by telephone, in-person at their regularly scheduled follow-up appointment, or by email, for less than 30 minutes using validated instruments and/or using a web-based REDCap survey. However, these surveys can also be completed during the subject's 180-day follow up visit with their doctor or a telephone follow-up. The follow up telephone call/visit will last for less than 30 minutes and will consist of a series of validated instruments/questionnaires. The following instruments will be used: Glasgow Outcome Scale Extended (GOSE) to ascertain functional status The GOSE score ranges from 1 to 8, with the minimum score of 1 indicating Death and the highest score of 8 representing a Good Recovery, signifying a good outcome and a return to pre-injury functioning.
180 days after discharging the hospital
Eligibility Criteria
Admitted to the University of Chicago Medical Center Neurocritical Care Unit
You may qualify if:
- Patients who are:
- Admitted to the University of Chicago Medical Center Neurocritical Care Unit
- Adults between 18 years and 80
- Admitted with Traumatic brain injury blunt and penetrating or nontraumatic intracerebral hemorrhage
- post-resuscitation Glasgow Coma Scale (GCS) \<9
You may not qualify if:
- Patients who were:
- Pre-existing heart failure
- Moribund or neurological exam suggesting imminent brain death (bilateral, fixed and dilated pupils) on admission
- Major polytrauma or admitted to the surgical trauma critical care service
- Prisoner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Chicagolead
- Baxter Healthcare Corporationcollaborator
Study Sites (1)
University of Chicago
Chicago, Illinois, 60637, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christos Lazaridis, MD
university of Chicago attending
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2024
First Posted
December 10, 2024
Study Start
December 6, 2024
Primary Completion (Estimated)
December 6, 2026
Study Completion (Estimated)
December 6, 2026
Last Updated
March 4, 2026
Record last verified: 2026-03